Order Article Reprints

Iwai N, Okuda T, Oka K, Sakagami J, Harada T, Ohara T, Hattori C, Taniguchi M, Sakai H, Hara T, et al. Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer. Cancers. 2021; 13(15):3860. https://doi.org/10.3390/cancers13153860

Iwai, Naoto, Takashi Okuda, Kohei Oka, Junichi Sakagami, Taishi Harada, Tomoya Ohara, Chie Hattori, Masashi Taniguchi, Hiroaki Sakai, Tasuku Hara, and et al. 2021. "Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer" Cancers 13, no. 15: 3860. https://doi.org/10.3390/cancers13153860

Iwai, N., Okuda, T., Oka, K., Sakagami, J., Harada, T., Ohara, T., Hattori, C., Taniguchi, M., Sakai, H., Hara, T., Tsuji, T., Komaki, T., Kagawa, K., Dohi, O., Yasuda, H., & Itoh, Y. (2021). Depletion of Psoas Muscle Mass after Systemic Chemotherapy Is Associated with Poor Prognosis in Patients with Unresectable Pancreatic Cancer. Cancers, 13(15), 3860. https://doi.org/10.3390/cancers13153860